MAPT and amyloidosis: Second, the APP/PS1ΔE9 model, while widely used and well-characterized for studying amyloid pathology, primarily recapitulates the amyloid-centric aspects of Alzheimer’s disease and does not fully exhibit tau pathology, extensive neurodegeneration, or the full spectrum of pathological features observed in human AD.